Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-11-000176
Filing Date
2011-01-20
Accepted
2011-01-20 09:47:39
Documents
1
Period of Report
2011-01-18

Document Format Files

Seq Description Document Type Size
1 zk1109327.html 4  
1 zk1109327.xml 4 3366
  Complete submission text file 0001178913-11-000176.txt   5340
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 20 HAIFA L3 31905 972-4-850-1080
PLURISTEM THERAPEUTICS INC (Issuer) CIK: 0001158780 (see all company filings)

EIN.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 63 RABUTZKY STREET RAANANA L3 43220
Business Address
Aberman Zami (Reporting) CIK: 0001344740 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31392 | Film No.: 11537458